CACNA1A antibody
Principal name
CACNA1A antibody
Alternative names for CACNA1A antibody
Cav2.1, Brain calcium channel I, CACH4, CACN3, CACNL1A4, Voltage-dependent P/Q-type calcium channel subunit alpha-1A, Voltage-gated calcium channel subunit alpha, Calcium channel L type alpha-1 polypeptide isoform 4
Ncbi ID
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB), Enzyme Immunoassay (E), Paraffin Sections (P)
Background of CACNA1A antibody
Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-16 to 21-28 in the coding region is associated with spinocerebellar ataxia 6.



Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA328721 | CACNA1A antibody |
||||||
| Rabbit Polyclonal Anti-CaV2.1 | |||||||
![]() |
Rabbit | Purified | Hu, Ms, Rt | WB |
0.2 ml /
€585.00
|
||
| OriGene Technologies, Inc. | |||||||
+1 additional image |
|||||||
| TA351022 | CACNA1A antibody |
||||||
| Rabbit Polyclonal Anti-CACNA1A Antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
+1 additional image |
|||||||
| AP05131PU-N | CACNA1A antibody |
||||||
![]() |
Rabbit | IgG | Purified | Rt | WB |
0.1 mg /
€400.00
|
|
| OriGene Technologies GmbH | |||||||
| AP05310PU-N | CACNA1A antibody |
||||||
![]() |
Rabbit | IgG | Aff - Purified | Rt | WB |
0.1 mg /
€400.00
|
|
| OriGene Technologies GmbH | |||||||
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC214314L1V | Lenti ORF particles, CACNA1A (Myc-DDK tagged) - Human calcium channel, voltage-dependent, P/Q type, alpha 1A subunit (CACNA1A), transcript variant 1, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€2,420.00
|
|
| OriGene Technologies, Inc. | ||
| RC214990L1V | Lenti ORF particles, CACNA1A (Myc-DDK tagged) - Human calcium channel, voltage-dependent, P/Q type, alpha 1A subunit (CACNA1A), transcript variant 2, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€2,420.00
|
|
| OriGene Technologies, Inc. | ||



+1 additional image

